Loading clinical trials...
Loading clinical trials...
Indication for use: "The Svelte DES is indicated for improving coronary luminal diameter in patients with symptomatic heart disease, including patients with non-ST elevation MI due to discrete de novo...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Svelte Medical Systems, Inc.
NCT04695106 · Atrial Fibrillation, Antithrombotic Therapy, and more
NCT06091319 · Acute Coronary Syndrome, Stroke, and more
NCT07329699 · Coronary Artery Disease, Chronic Coronary Syndrome, and more
NCT06845826 · Acute Coronary Syndromes
NCT07436429 · Myocardial Infarction (MI), ST-Elevation Myocardial Infarction, and more
Thomas Hospital
Fairhope, Alabama
Scottsdale Healthcare
Scottsdale, Arizona
Arkansas Heart Hospital
Little Rock, Arkansas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions